Menu
Get Started
Personalized
GLP-1
Treatments
GLP-1
Treatments
From $119 first month*
*First month discount on 3-month plan.
Please see Important Safety Information below for intended use, potential risks and side effects, use in specific populations, and drug interactions of advertised prescription treatments.
TideMD encourages the reporting of any adverse side effects of medications to the medical professional and the distributing pharmacy. Additionally, to report suspected adverse reactions to acarbose contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go seek care at the nearest emergency room.
Advertisements from TideMD.com are paid for by TideMD Inc. for the purposes of advertising and marketing TideMD services. Advertisements may include paid actors or actor portrayals. Advertisements including testimonials, endorsements, or real TideMD users will be indicated as such. Medication and program results may vary and there is no guarantee of any given outcome.
TideMD offers and facilitates access to consultations with licensed medical professionals to determine medical appropriateness for advertised treatments and plans. TideMD, through its services, may facilitate fulfillment of prescriptions through its third-party pharmacy network. TideMD, as a managed services organization, does not provide medical advice and does not fulfill prescription medication and is not licensed as a medical provider or a pharmacy. TideMD offers software and technology services to facilitate medical consultation and fulfillment of prescription medications. For further information, please see TideMD’s Terms of Service.
Advertisements from TideMD.com may include, from time to time, special or introductory offers for promotional pricing of services. All advertised offers from TideMD.com are only available for 24 hours following removal of the offer from the website and automatically expire thereafter.
All offers are subject to additional terms and conditions including:
Prescription medications require a medical consultation and prescription with a licensed healthcare provider. Writing of a prescription is solely determined by the medical professional and access to medications and treatment plans is in no way guaranteed. Prescriptions written by medical professionals may be available through TideMD software services and may be fulfilled by licensed pharmacies.
Prescription medications carry risks. To review a full list of risks and side effects, please see "Important Safety Information" and speak with your doctor regarding potential risks or side effects.
Medical professionals may issue prescriptions to compounded medications that can be filled by licensed USA-based compounding pharmacies. Compounded medications are not approved by the FDA for safety or effectiveness but may be prescribed during drug shortages or when commercially available FDA-approved drugs do not meet patient needs.
TideMD may facilitate the filling of FDA-approved medications or compounded medications through a network of licensed pharmacies throughout the US. Medication may be compounded based on a healthcare provider's prescription to meet the specific needs of the patient, which may differ from commercially available products. For medications compounded during drug shortages, FDA-approved medications may be available.
For questions related to TideMD’s advertisements or services, please contact care@tidemd.com.
*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Never share the semaglutide with other people.
As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your healthcare provider about your medical history prior to taking semaglutide.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.
*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing trizepatide are available.
Compounded tirzepatide usage has been associated with the potential development of thyroid tumors, including thyroid cancer. Watch for any potential symptoms, such as neck lumps or swelling, hoarseness, difficulty swallowing, or breathlessness. Should any of these symptoms arise, it is imperative to inform your healthcare provider promptly.
Avoid using compounded tirzepatide if you or any family members have a history of medullary thyroid carcinoma (MTC), a specific type of thyroid cancer. Similarly, refrain from its use if diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you've previously experienced a severe allergic reaction to tirzepatide or any of its components.
Compounded tirzepatide carries the risk of severe side effects, which include:
The most frequently reported side effects of compounded tirzepatide include:
These side effects are not exhaustive. Should you experience any persistent or bothersome side effects, discuss them with your healthcare provider for appropriate management.
Tell your healthcare provider if you have any side effects.
To report suspected severe side effects or adverse reactions to compounded trizepatide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergencies, please call 911 or go to the nearest emergency room.
As with other medications, compounded trizepatide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded trizepatide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded trizepatide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded trizepatide.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
Tirzepatide may alter the efficacy of birth control pills. Talk with your doctor before starting tirzepatide if you are on birth control. Your healthcare provider may recommend another type of birth control for 4 weeks after you start tirzepatide and for 4 weeks after each increase in your dose.
Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
These symptoms are typically mild and short-lived, especially when injections are administered slowly. Rotating injection sites can help minimize local irritation.
If any of these occur, discontinue use and contact your healthcare provider immediately.
Glutathione injections are not recommended during pregnancy or while breastfeeding due to a lack of controlled safety data. Speak with your provider if you are pregnant, nursing, or planning to conceive.
Keep out of reach of children. Do not use expired product.
Patients should consult their healthcare provider if they have questions about side effects, injection technique, or whether glutathione is appropriate for their health goals.
Disclaimer: Glutathione injections provided through TideMD are compounded and prescribed off-label by licensed healthcare providers. These formulations are not FDA-approved. Statements above have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
NAD+ Injection
These effects are generally mild and short-lived. Rotate application or injection sites and follow provider guidance to reduce the risk of irritation.
If you experience signs of an allergic reaction or severe discomfort, stop treatment and seek medical care immediately.
NAD+ products are not recommended during pregnancy or while breastfeeding, as safety data in these populations is limited. Discuss alternative options with your provider if you are planning to become pregnant or nursing.
Keep all formulations out of reach of children. Do not use any product past its expiration date.
Patients should consult their healthcare provider if they have any questions about their dosing, formulation type, side effects, or treatment options. Never modify or exceed the dosing schedule without medical supervision.
Disclaimer: The NAD+ formulations offered through TideMD are compounded and prescribed off-label by licensed providers. These medications are not approved by the FDA. Statements above are for educational purposes and have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
